Search results
Prostate cancer: Supplement, keto diet may boost immunotherapy
Medical News Today· 4 days agoAbout 13% of cisgender men around the world will receive a prostate cancer diagnosis in their...
Trelstar dosage: Form, strengths, how to use, and more
Medical News Today· 5 days agoTrelstar (triptorelin pamoate) is a brand-name drug that’s prescribed for advanced prostate cancer...
These Are the Drugs America Is Running Short On
247wallst.com· 7 days agoDrug shortages in America are the result of supply line challenges, profit-based operations, and company closures.
King Charles III’s openness about cancer has helped him connect with people in year after coronation
WKBN 27 Youngstown· 1 day agoLONDON (AP) — King Charles III’s decision to be open about his cancer diagnosis has helped the new...
Novartis to buy radiology drug specialist Mariana for $1 billion
Reuters via AOL· 4 days agoNovartis agreed to acquire U.S. radiopharmaceutical company Mariana Oncology for $1 billion upfront,...
Angle to Develop Prostate Cancer Liquid Biopsy Assay for AstraZeneca
GenomeWeb News· 3 days agoAngle announced on Friday that it has signed a supplier agreement with AstraZeneca to develop an androgen receptor (AR) assay to assess prostate cancer ...
Angle PLC Announces New Commercial Agreement with Large Pharma
Digital Journal· 3 days agoANGLE commissioned to develop a Parsortix-based Androgen Receptor detection assay for use in prostate cancer studies GUILDFORD, SURREY / ACCESSWIRE / May ...
GT Medical and Theragenics team up to expand access to radiotherapy seeds
Medical Device Network via Yahoo Finance· 4 days agoCesium-131 is a common isotope used with low dose rate (LDR) brachytherapy, a radiation treatment...
Why selling to Novartis made sense for Mariana
BioPharma Dive via Yahoo Finance· 3 days agoNovartis’ success with Pluvicto in prostate cancer has motivated others, Mariana among them, to follow into the field. “We began thinking in mid-2020...
Phase 2 data for ERLEADA® (apalutamide) plus androgen deprivation therapy following radical...
FOX 4 Kansas City· 3 days agoJohnson & Johnson announced today results from the open-label, single-arm Phase 2 Apa-RP study...